Compare DX & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DX | ITGR |
|---|---|---|
| Founded | 1987 | 1970 |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | N/A | 2000 |
| Metric | DX | ITGR |
|---|---|---|
| Price | $13.65 | $85.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $14.25 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 5.1M | 968.0K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 14.91% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.89 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | ★ $5.66 | $29.90 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $10.79 | $62.00 |
| 52 Week High | $14.93 | $127.56 |
| Indicator | DX | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 35.37 | 47.51 |
| Support Level | $13.12 | $83.08 |
| Resistance Level | $13.72 | $87.54 |
| Average True Range (ATR) | 0.26 | 3.51 |
| MACD | -0.04 | -0.26 |
| Stochastic Oscillator | 13.77 | 12.15 |
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.